The genetic testing services market is poised for robust growth, with substantial advancements in genetic technologies and ...

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine class of drugs. TPMT∗8 is relatively common in individuals of African or ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today provided an update on its engagement with UnitedHealthcare (UNH) following the Nov 1, 2024 publication ...

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine ...

Mayo Clinic researchers found that a gene variant, the TPMT∗8 allele, is associated with reduced metabolism of the thiopurine class of drugs. TPMT∗8 is relatively common in individuals of African or ...

Consistent data from high-quality clinical studies will better inform clinical practices, guidelines and policy decisions, ...

Request To Download Free Sample of This Strategic Report @- For instance, Genetic testing has been widely used in pharmacogenomics, also referred as drug-gene testing. In addition, advancements in ...

Rising Prevalence of Genetic Illnesses and Cancer: The increasing incidence of genetic disorders and cancer is propelling the demand for genetic testing in the United States. As awareness grows and ...

Out of the 30 companies tracked by 360Dx, 13 saw their share prices increase, while 17 saw their stock prices decline.

The Missouri hospital system designed its own 13-gene PGx panel, which it runs at its molecular genetics lab and calls the ...

In addition, they emphasized that the CPIC (Clinical Pharmacogenetics Implementation Consortium) and FDA (Food and Drug Administration) advocate for the use of PGx testing, specifically testing CYP2D6 ...